Pellagra and peripheral neuropathy secondary to tuberculosis treatment-Reference-Cited by-同舟云学术

Pellagra and peripheral neuropathy secondary to tuberculosis treatment

Published:2023-05-02 Issue:8 Volume:116 Page:696-698
ISSN:1460-2725
Container-title:QJM: An International Journal of Medicine
language:en
Short-container-title:

Author:

Wang J¹,Yu J²,Huang X³

Affiliation:

1. M.D. Program, Peking Union Medical College, Chinese Academy of Medical Science , No. 9 Dongdansantiao, Dongcheng District , 100730 Beijing, China

2. Department of Internal Medicine, Peking Union Medical College Hospital, Chinese Academy of Medical Science , No. 1, Shuaifuyuan, Wangfujing Street, Dongcheng District , 100730 Beijing, China

3. Department of General Internal Medicine, Peking Union Medical College Hospital, Chinese Academy of Medical Science , No. 1, Shuaifuyuan, Wangfujing Street, Dongcheng District , 100730 Beijing, China

Funder

National High Level Hospital Clinical Research Funding

Publisher

Oxford University Press (OUP)

Subject

General Medicine

Link

https://academic.oup.com/qjmed/advance-article-pdf/doi/10.1093/qjmed/hcad077/50453952/hcad077.pdf

Reference6 articles.

1. Preventing pellagra during isoniazid preventive treatment;Kapata;Lancet Glob Health,2022

2. Isoniazid-associated pellagra during mass scale-up of tuberculosis preventive therapy: a case-control study;Nabity;Lancet Glob Health,2022

3. Isoniazid-induced pellagra in a patient with Crohn’s disease;Kchir;Clin Case Rep,2020

4. Drug-induced peripheral neuropathy;Vilholm;Basic Clin Pharmacol Toxicol,2014

5. Cross-resistance of isoniazid, para-aminosalicylic acid and pasiniazid against isoniazid-resistant Mycobacterium tuberculosis isolates in China;Li;J Glob Antimicrob Resist,2020